TerraBind Solves Critical Computational Bottleneck in AI-driven Drug DiscoveryLOS ANGELES--(BUSINESS WIRE)--#biotech--Terray ...

The global electronics manufacturing and new energy sectors are witnessing a significant surge in demand for advanced testing ...

BDC Labs cuts silicone production time by 75% and upgrades heart valve testing with real-time imaging and analysis features.

In a welcome return to active flight vehicle testing after setbacks and facility upgrades, SpaceX made strong progress with Super Heavy Booster 19 (B19) at its Massey’s test site before returning it ...

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

Digital twins and prognostic models deliver detailed insights into a battery’s behaviour and lifespan, and machine learning..

Cashflow is a chief concern for ASX investors. Small caps OMG Group and Clever Culture are repaying the faith after turning cash positive.

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in an effort to improve efficiency and cut costs.

Given the absence of lumps in the drinks, there's minimal residue to contend with. The appliance bears resemblance to B&M's ...

Bristol Myers Squibb (NYSE:BMY) executives emphasized “focused execution” in 2025 and pointed to continued momentum entering ...

Soccer Hall-of-Famer is speaking out for the first time about his private battle with lymphoma and treatment with Breyanzi in ...